(Q34984035)

5 August 2017

1 reference

title

The burden of hepatitis C in the United States (English)

1 reference

5 August 2017

United States of America

0 references

1 reference

W Ray Kim

1

1 reference

PubMed ID

12407574

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

36

1 reference

5 August 2017

S30-4

1 reference

5 August 2017

5 Suppl 1

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

5 August 2017

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36791

Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36791

Viral hepatitis and other infectious diseases in a homeless population

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36791

Hepatitis C and the correctional population

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36791

Epidemiology of hepatitis C in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36791

Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36791

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36791

Outcome of hospital care of liver disease associated with hepatitis C in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36791

Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36791

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36791

The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36791

Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36791

The impact of diagnosis of hepatitis C virus on quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36791

The burden of selected digestive diseases in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36791

21 January 2018

Identifiers

DOI

10.1053/JHEP.2002.36791

1 reference

5 August 2017

1 reference

PubMed ID

12407574